We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.79B
AUM Growth
-$730M
Cap. Flow
-$661M
Cap. Flow %
-23.73%
Top 10 Hldgs %
39.61%
Holding
2,225
New
423
Increased
362
Reduced
424
Closed
673
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOAC
1026
DELISTED
Talon 1 Acquisition Corp. Class A Ordinary Shares
TOAC
$215K 0.01%
21,076
-5
-0% -$51
WBX
1027
Wallbox
WBX
$81M
$214K 0.01%
1,356
+514
+61% +$91.6K
WHR icon
1028
Whirlpool
WHR
$2.86B
$214K 0.01%
1,589
-255
-14% -$40.6K
QTRX icon
1029
Quanterix
QTRX
$116M
$213K 0.01%
+19,290
New +$245K
EBIX
1030
CALL
DELISTED
Ebix Inc
EBIX
$213K 0.01%
990,800
+716,400
+261% +$15.8M
ACLX
1031
DELISTED
Arcellx
ACLX
$212K 0.01%
+11,300
New +$216K
ASTL icon
1032
Algoma Steel
ASTL
$475M
$211K 0.01%
32,746
-7,322
-18% -$65.4K
ELAN icon
1033
Elanco Animal Health
ELAN
$11.4B
$211K 0.01%
+17,021
New +$298K
WIX icon
1034
WIX.com
WIX
$2.74B
$211K 0.01%
+2,696
New +$186K
JCI icon
1035
Johnson Controls International
JCI
$93.2B
$210K 0.01%
+4,273
New +$227K
BDC icon
1036
Belden
BDC
$5.34B
$209K 0.01%
3,480
-2,183
-39% -$139K
BDX icon
1037
Becton Dickinson
BDX
$49.1B
$208K 0.01%
+932
New +$232K
AMPS
1038
DELISTED
Altus Power
AMPS
$208K 0.01%
18,872
-4,243
-18% -$40.4K
NBIX icon
1039
Neurocrine Biosciences
NBIX
$16.5B
$207K 0.01%
+1,948
New +$198K
SNDR icon
1040
Schneider National
SNDR
$6.1B
$205K 0.01%
10,110
-1,136
-10% -$26.4K
SYNA icon
1041
Synaptics
SYNA
$4.16B
$205K 0.01%
+2,068
New +$257K
ARKG icon
1042
CALL
ARK Genomic Revolution ETF
ARKG
$1.79B
$204K 0.01%
6,600
CRL icon
1043
Charles River Laboratories
CRL
$13.4B
$204K 0.01%
1,038
-198
-16% -$42.7K
PARR icon
1044
Par Pacific Holdings
PARR
$3.75B
$203K 0.01%
+12,341
New +$209K
SPEC
1045
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$203K 0.01%
20,016
+15,012
+300% +$404K
ACDI
1046
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
$203K 0.01%
20,000
CTAQ
1047
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$203K 0.01%
+20,385
New +$202K
NVRO
1048
DELISTED
NEVRO CORP.
NVRO
$202K 0.01%
+4,332
New +$201K
BCC icon
1049
Boise Cascade
BCC
$2.99B
$201K 0.01%
+3,379
New +$217K
HCC icon
1050
Warrior Met Coal
HCC
$5.1B
$201K 0.01%
+7,074
New +$218K

Similar funds

Prelude Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Prelude Capital Management held 2,225 positions worth $2.79B, down 21% from $3.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management withdrew a net $661M in Q3 2022, closing 673 positions and reducing 424 holdings. Its most notable exit was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $30.7M.

  • Prelude Capital Management's largest Q3 2022 buy was KKR Acquisition Holdings I Corp.: 3,123,025 shares worth $30.7M.
  • Prelude Capital Management added most to Twitter, Inc. in Q3 2022, an estimated $23.5M increase.
  • Prelude Capital Management's biggest Q3 2022 reduction was Lockheed Martin, cutting an estimated $83M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q3 2022, selling an estimated $43.2M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $2.79B portfolio in Q3 2022.
  • Prelude Capital Management opened 423 new positions and closed 673 in Q3 2022.
  • Prelude Capital Management's portfolio value fell 21% quarter-over-quarter to $2.79B.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.